Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Perspectives on osteoporosis in pediatric inflammatory bowel disease.

Literature DB >> 12734045

Perspectives on osteoporosis in pediatric inflammatory bowel disease.

Abstract

Osteoporosis is now recognized as a problem in children with chronic illness. Decreased bone mineral density and increased risk of fracture have been reported in children with inflammatory bowel disease (IBD). Recent studies have led to a better understanding of the pathogenesis of bone loss. There are many risk factors for osteopenia and osteoporosis in children with IBD. Dual-energy x-ray absorptiometry remains the diagnostic procedure of choice for assessment of bone mineral density, but other modalities are being explored. Guidelines for diagnosis and treatment of osteoporosis in children have not been established. This article reviews the current understanding of osteopenia and osteoporosis in children with IBD.

Entities: Disease Species

Mesh：

Year: 2003 PMID： 12734045 DOI： 10.1007/s11894-003-0024-8

Source DB: PubMed Journal: Curr Gastroenterol Rep ISSN： 1522-8037

Keyword Cloud
References

92 in total

1. Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: cross-sectional data from a population-based study.

Authors: G Haugeberg; K Vetvik; A Stallemo; H Bitter; B Mikkelsen; M Stokkeland
Journal: Scand J Gastroenterol Date: 2001-07 Impact factor: 2.423

Review 2. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

Authors: L C Hofbauer; S Khosla; C R Dunstan; D L Lacey; W J Boyle; B L Riggs
Journal: J Bone Miner Res Date: 2000-01 Impact factor: 6.741

3. Inflammatory bowel disease and predisposition to osteopenia.

Authors: F J Cowan; J T Warner; F D Dunstan; W D Evans; J W Gregory; H R Jenkins
Journal: Arch Dis Child Date: 1997-04 Impact factor: 3.791

Review 4. Inflammatory bowel disease and osteoporosis.

Authors: H Andreassen; J Rungby; J F Dahlerup; L Mosekilde
Journal: Scand J Gastroenterol Date: 1997-12 Impact factor: 2.423

5. Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women.

Authors: S L Greenspan; H N Rosen; R A Parker
Journal: J Clin Endocrinol Metab Date: 2000-10 Impact factor: 5.958

Perspectives on osteoporosis in pediatric inflammatory bowel disease.

1. Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: cross-sectional data from a population-based study.

Review 2. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

3. Inflammatory bowel disease and predisposition to osteopenia.

Review 4. Inflammatory bowel disease and osteoporosis.

5. Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women.

6. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease.

7. Interleukin-6 inhibits bone formation in vitro.

8. Interpretation of bone mineral density values in pediatric Crohn's disease.

9. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group.

10. Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo.